|
Prognosis and
Outcome top |
|
|
Contents
|
|
|
|
|
|
|
Astrocytic
Tumors
|
|
|
|
Arienti VM, Botturi A, Boiardi A, Broggi G, Collice M, Fariselli L,
Zanni D, Botturi M
Adult
brain low-grade astrocytomas: survival after surgery and radiotherapy
Neurol
Sci 2001 Jun;22(3):233-8
|
|
D.
C. Bowers, P. Kapur, N. J. Winick, L. R. Margraf
MIB-1 labeling index as a predictor of tumor
progression in pilocytic astrocytomas in children and adolescents
39th ASCO Annual Meeting.
Chicago, IL. May 31-June 3, 2003.
Abstract No. 445
|
|
|
Alba A. Brandes, Linda Nicolardi,
Alicia Tosoni, Marina Gardiman, Paolo Iuzzolino,
Claudio Ghimenton, Michele Reni, Antonino
Rotilio, Guido Sotti and Mario Ermani
Survival following adjuvant PCV or temozolomide for anaplastic astrocytoma
Neuro-oncol 2006 Jul 1; 8(3):253-260; Epub 2006 May 24
Abstract
|
|
Daniel
J. Brat, Wendy F. Seiferheld, Arie Perry, Elizabeth H. Hammond, Kevin J. M Urray,
Alan R. Schulsinger, Minesh P. Mehta, Walter J. Curran
Analysis
of 1p, 19q, 9p, and 10q as prognostic markers for high-grade astrocytomas using
fluorescence in situ hybridization on tissue microarrays from Radiation Therapy
Oncology Group trials
Neuro-Oncology,
April 2004, Volume 6, Number 2, Pages 96 – 103.
|
|
Burkhard C, Di Patre PL, Schuler D, Schuler G, Yasargil MG,
Yonekawa Y, Lutolf UM, Kleihues P, Ohgaki H
A
population-based study of the incidence and survival rates in patients with
pilocytic astrocytoma
J Neurosurg. 2003 Jun;98(6):1170-4
|
|
Basil F. El-Rayes, Camille S. Norton,
Wael Sakr, Zosia Maciorowski, Daryn Smith, Haline Pietraszkiewicz,
Maria Del Mar Alonso and John F. Ensley
Cellular DNA content parameters as
prognostic indicators in human astrocytomas
 Journal
of Neuro-Oncology, 71(2):
85-89, January 2005. (Abstract+)
|
|
Giannini
C, Scheithauer BW, Burger PC, Brat DJ, Wollan PC, Lach B, O'Neill BP
Pleomorphic
xanthoastrocytoma: what do we really know about it?
Cancer. 1999 May
1;85(9):2033-45.
|
|
Hanzely
Z, Polgar C, Fodor J, Brucher JM, Vitanovics D, Mangel LC, Afra D
Role
of early radiotherapy in the treatment of supratentorial WHO Grade II
astrocytomas: long-term results of 97 patients
J Neurooncol. 2003 Jul;63(3):305-12
|
|
Hwang SL,
Yang YH, Lieu AS, Chuang MC, Chang SJ, Chang YY, Lin HJ, Howng SL
The
conditional survival statistics for survivors with primary supratentorial
astrocytic tumors
J Neurooncol. 2000 Dec;50(3):257-64.
|
|
Keles GE, Chang EF, Lamborn KR, Tihan T, Chang CJ, Chang SM,
Berger MS.
Volumetric extent of resection and residual
contrast enhancement on initial surgery as predictors of outcome in adult
patients with hemispheric anaplastic astrocytoma.
J Neurosurg.
2006 Jul;105(1):34-40.
Abstract
|
Reprint
|
|
Kirla
RM, Haapasalo HK, Kalimo H, Salminen EK
Low
expression of p27 indicates a poor prognosis in patients with high-grade
astrocytomas
Cancer 2003 Feb 1;97(3):644-8
|
|
|
Kostic
A, Mihailovic D, Veselinovic S, Tasic G, Radulovic D, Stefanovic I.
Peritumoral edema and karyometric variables in astrocytoma of the brain.
J
BUON. 2007 Apr-Jun;12(2):239-43.
PMID: 17600879 [PubMed - in process]
|
|
Lin CL, Lieu AS, Lee KS, Yang YH, Kuo TH, Hung MH, Loh JK, Yen CP,
Chang CZ, Howng SL, Hwang SL
The
conditional probabilities of survival in patients with anaplastic
astrocytoma or glioblastoma multiforme
Surg Neurol.
2003 Nov;60(5):402-6.
|
|
Christian
Plathow M.D., Daniela Schulz-Ertner M.D., Christoph Thilman M.D., Ivan
Zuna Ph.D., Mathias Lichy M.D., Marc-André Weber M.D., Heinz-Peter
Schlemmer M.D., Michael Wannenmacher M.D. and Jürgen Debus M.D., Ph.D.
Fractionated
stereotactic radiotherapy in low-grade astrocytomas: Long-term outcome and
prognostic factors
Int J of
Radiation Oncology*Biology*Physics, Volume 57, Issue 4, 15 November 2003,
Pages 996-1003
|
|
Ravi
D Rao, Bernd W Scheithauer, Caterina Giannini, Nancy L Iturria, Judith
R O'Fallon, Paul L Schaefer, Jan C Buckner
Prognostic
significance of histologic subtyping in high grade astrocytoma: North
Central Cancer Treatment Group (NCCTG) results
38th
ASCO Annual Meeting. Orlando, FL. May 18-21, 2002.
283
|
|
Stella
M. Ranuncolo, Mirta
Varela, Ana Morandi, José Lastiri, Silvia Christiansen, Elisa Bal de Kier
Joffé, María G. Pallotta, Lydia Puricelli
Prognostic Value of
Mdm2, p53 and p16 in Patients with Astrocytomas
Journal of Neuro-Oncology, 68 (2): 113-121, June 2004.
(Abstract+)
|
|
|
Sathornsumetee S, Cao Y, Marcello JE, Herndon JE
2nd, McLendon RE, Desjardins A, Friedman HS, Dewhirst MW, Vredenburgh JJ,
Rich JN
Tumor angiogenic and hypoxic profiles predict radiographic response and
survival in malignant astrocytoma patients treated with bevacizumab and
irinotecan
J
Clin Oncol. 2008 Jan 10;26(2):271-8
Abstract |
DBLinks | BL 7:6
|
|
Torp
SH
Diagnostic
and prognostic role of Ki67 immunostaining in human astrocytomas using
four different antibodies
Clin Neuropathol 2002 Nov-Dec;21(6):252-7
|
|
Wessels
PH, Hopman AH, Kubat B, Kessels AG, Hoving EW, Ummelen MI, Ramaekers
FC, Twijnstra A
Proliferation
and aneusomy predict survival of young patients with astrocytoma grade II
Br J Cancer. 2003 Jul 7;89(1):128-34
|
|
|
Brain
Tumors
|
|
|
|
Davis
FG, McCarthy BJ, Freels S, Kupelian V, Bondy ML
The conditional probability of survival of patients
with primary malignant brain tumors: surveillance, epidemiology, and end
results (SEER) data
Cancer. 1999 Jan 15;85(2):485-91.
|
|
Lori
A. Holmquist, Jim Scott
Treatment, Age, and Time-Related Predictors of
Behavioral Outcome in Pediatric Brain Tumor Survivors
Journal of Clinical Psychology in Medical Settings, 9 (4): 315-321, December
2002
|
|
T. B. Johannesen, F. Langmark and K. Lote
Cause of death and long-term survival in patients
with neuro-epithelial brain tumours: a population-based study
European Journal of Cancer, Volume 39, Issue 16 , November 2003, Pages 2355-2363
|
|
B.
E. Lally, J. Lacy, J. M. Piepmeier, J. M. Baehring, D. B. Fischer, J.
P. S. Knisely
Survival
analysis for patients with primary brain tumors treated with temozolomide
39th ASCO Annual Meeting.
Chicago, IL. May 31-June 3, 2003. Abstract
No. 453
|
| |
Yael
Mardor, Roberto Spiegelmann, Yiftach Roth, Arie Orenstein, Stephan E. Maier,
Ouzi Nissim, Zvi Ram, Jacob Baram, Thomas Tichler, Raphael Pfeffer
Pre-treatment prediction of brain
tumor response to radiation therapy using high diffusion-weighted MRI
Proceedings of the AACR, Volume 44, 2nd ed., July 2003, Abstract No. 2547
|
| |
Mardor Y,
Pfeffer R, Spiegelmann R, Roth Y, Maier SE, Nissim O, Berger R, Glicksman A,
Baram J, Orenstein A, Cohen JS, Tichler T
Early
Detection of Response to Radiation Therapy in Patients With Brain Malignancies
Using Conventional and High b-Value Diffusion-Weighted Magnetic Resonance
Imaging
J Clin Oncol 2003 Mar 15;21(6):1094-100
|
|
Helen McCarter, William
Furlong, Anthony C. Whitton, David Feeny,
Sonja DePauw, Andrew R. Willan, Ronald D.
Barr
Health Status Measurements at Diagnosis
As Predictors of Survival Among Adults With Brain Tumors
Journal of Clinical Oncology, Vol 24, No 22 (August 1), 2006: pp.
3636-3643, DOI: 10.1200/JCO.2006.06.0137
|
|
Meyers
CA, Hess KR
Multifaceted
end points in brain tumor clinical trials: Cognitive deterioration
precedes MRI progression
Neuro-oncol 2003 Apr;5(2):89-95
|
|
|
Pang
J, Banerjee A, Tihan T.
The value of tandem CSF/MRI evaluation for predicting disseminated disease
in childhood central nervous system neoplasms.
J Neurooncol.
2007 Nov 7; [Epub ahead of print]
Abstract
|
|
A
A. Tzika, Loukas G. Astrakas, David Zurakowski, Maria K. Zarifi, Tina P.
Young, Liliana Goumnerova, Douglas C. Anthony, Mark Kieran, Nancy J. Tarbell,
Peter M. Black
Predicting progression in children with
pediatric brain tumors using magnetic resonance neuroimaging
Proceedings of the AACR, Volume 44, 1st ed., March 2003, Abstract No. 3411
|
|
|
Brainstem
Gliomas
|
|
|
|
|
Panigrahy A, Nelson Jr MD, Finlay JL, Sposto R,
Krieger MD, Gilles FH, Blüml S.
Metabolism of diffuse intrinsic brainstem gliomas in children.
Neuro Oncol. 2007
Nov 14; [Epub ahead of print]
Abstract
|
DBLinks
|
|
|
Central
Neurocytoma |
|
|
|
Rades D, Schild SE, Fehlauer F
Prognostic value of the MIB-1 labeling index for
central neurocytomas
Neurology. 2004 Mar 23;62(6):987-9
|
|
|
Choriocarcinoma
|
|
|
|
Shinoda J, Sakai N, Yano H, Hattori T, Ohkuma A,
Sakaguchi H
Prognostic factors and therapeutic problems of
primary intracranial choriocarcinoma/germ-cell tumors with high levels of
HCG
J Neurooncol. 2004 Jan;66(1-2):225-40
|
|
|
Craniopharyngioma |
|
|
|
Losa M, Vimercati A, Acerno S, Barzaghi RL, Mortini P, Mangili F, Terreni
MR, Santambrogio G, Giovanelli M
Correlation between clinical characteristics and
proliferative activity in patients with craniopharyngioma
J Neurol Neurosurg Psychiatry. 2004 Jun;75(6):889-92
|
|
|
Ependymal
Tumors
|
|
|
|
Altura RA,
Olshefski RS, Jiang Y, Boue DR
Nuclear
expression of Survivin in paediatric ependymomas and choroid plexus tumours
correlates with morphologic tumour grade
Br J Cancer. 2003 Nov 3;89(9):1743-9
|
|
D. R. Gomez, B. T. Missett,
W. M. Wara, D. A. Larson, P. K. Sneed, M. D. Prados, S. M. Chang, M. S.
Berger, N. Gupta, D. A. Haas-Kogan;
High
failure rate in spinal ependymomas with long-term follow-up
40th
ASCO Annual Meeting. New Orleans, LA. June 5-8, 2004. Abstract No.1528
|
|
Tang-Her
Jaing, Huei-Shyong Wang, Pei-Kwei Tsay, Chen-Kan Tseng, Shih-Ming Jung,
Kuang-Lin Lin, Tai-Ngar Lui
Multivariate Analysis of
Clinical Prognostic Factors in Children with Intracranial Ependymomas
Journal of Neuro-Oncology, 68 (3): 255-261, July 2004. (Abstract+)
|
| |
Bong-Soo
Kim, Chanland Roonprapunt, Victoria LaMarca, Karl F Kothbauer, George
I Jallo
The
current management of intracranial ependymomas in children
Annals of Neurosurgery 2002; 2(3), July 2002
|
|
Korshunov A, Golanov A, Sycheva R, Timirgaz V
The histologic grade
is a main prognostic factor for patients with intracranial ependymomas
treated in the microneurosurgical era: an analysis of 258 patients
Cancer. 2004 Mar 15;100(6):1230-7
|
|
|
Monoranu
CM, Huang B, Zangen IL, Rutkowski S, Vince GH, Gerber NU, Puppe B,
Roggendorf W
Correlation between 6q25.3 deletion status and survival in pediatric
intracranial ependymomas
Cancer
Genet Cytogenet. 2008 Apr 1;182(1):18-26;
Epub 2008 Mar 6
Abstract |
DBLinks | BL 7:9
|
|
Reni M, Brandes AA, Vavassori V, Cavallo G, Casagrande
F, Vastola F, Magli A, Franzin A, Basso U, Villa E
A multicenter study of the prognosis and treatment
of adult brain ependymal tumors
Cancer. 2004 Mar 15;100(6):1221-9
|
|
|
Uri Tabori,
Jing Ma, Michael Carter, Maria Zielenska,
James Rutka, Eric Bouffet, Ute Bartels,
David Malkin, Cynthia Hawkins
Human Telomere Reverse Transcriptase Expression Predicts Progression
and Survival in Pediatric Intracranial Ependymoma
Journal of Clinical Oncology, Vol 24, No 10 (April 1), 2006: pp.
1522-1528; DOI: 10.1200/JCO.2005.04.2127
Abstract
|
News
|
|
|
Epilepsy
|
|
|
|
|
Maschio
M, Dinapoli L, Zarabla A, Pompili A, Carapella CM, Pace A, Giannarelli D,
Occhipinti E, Jandolo B.
Outcome and tolerability of topiramate in brain tumor associated epilepsy.
J Neurooncol.
2007 Jun 28; [Epub ahead of print]
PMID: 17598071 [PubMed - as supplied by publisher]
|
|
|
Germinoma
|
|
|
|
Alyssa
T. Reddy, John C. Wellons III, Jeffrey C. Allen, John B. Fiveash,
Hussein Abdullatif, Karen W. Braune, Paul A. Grabb
Refining the staging evaluation of pineal region
germinoma using neuroendoscopy and the presence of preoperative diabetes
insipidus
Neuro-OncologyVolume 6, Number 2, Pages 127 – 133
|
|
|
Glioblastoma
|
|
|
|
|
Aoki H, Yokoyama T, Fujiwara K, Tari AM, Sawaya
R, Suki D, Hess KR, Aldape KD, Kondo S, Kumar R, Kondo Y.
Phosphorylated Pak1 Level in the Cytoplasm Correlates with Shorter
Survival Time in Patients with Glioblastoma.
Clin
Cancer Res. 2007 Nov 15;13(22):6603-6609.
Abstract
|
DBLinks
|
|
|
G. L. Banna, R. Pallini, L. Ricci-Vitiani, M.
Signore, D. Lombardi, M. Martini, G. Maira, D. Giuffrida, L. M. Larocca, and
R. De Maria
High prognostic potential of glioblastoma
stem
cell analysis
ASCO Meeting Abstracts, Jun 2007; 25: 10580
Abstract |
DBLinks | BL 7:2
|
|
Barker
FG 2nd, Prados MD, Chang SM, Gutin PH, Lamborn KR, Larson DA, Malec MK,
McDermott MW, Sneed PK, Wara WM, Wilson CB.
Radiation
response and survival time in patients with glioblastoma multiforme
J Neurosurg 1996
Mar;84(3):442-8
|
|
Barker
FG 2nd, Chang SM, Gutin PH, Malec MK, McDermott MW, Prados MD, Wilson CB
Survival
and functional status after resection of recurrent glioblastoma multiforme
Neurosurgery. 1998 Apr;42(4):709-20
|
|
J.L.
Blanc, M. Wager, J. Guilhot, S. Kusy, B. Bataille, T. Chantereau, F.
Lapierre, C.J. Larsen, L. Karayan-Tapon
Correlation of
Clinical Features and Methylation Status of MGMT Gene Promoter in Glioblastomas
Journal of Neuro-Oncology, 68 (3): 275-283, July 2004. (Abstract+)
|
|
L.
Butttolo, F. Giunta, V. D. Ferrari, G. Marini
Temozolomide
in glioblastoma: 4 years' experience with monthly or fortnigthly schedule
39th
ASCO Annual Meeting. Chicago, IL. May 31-June 3, 2003. Abstract
No. 437
|
|
A. K. Choucair, W. Seiferheld, C.
Ford, J. Hansen, B. Dabbas, C. Schultz, A. Schulsinger, M. Mehta, W. Curran
Long term survivors with glioblastoma multiforme
(GBM) treated on RTOG protocols with irradiation and nitrosurea have higher
initial expression of Ki-67
40th
ASCO Annual Meeting. New Orleans, LA. June 5-8, 2004. Abstract No.9661
|
|
|
Filippini G, Falcone C, Boiardi A, Broggi G,
Bruzzone MG, Caldiroli D, Farina R, Farinotti M, Fariselli L, Finocchiaro G,
Giombini S, Pollo B, Savoiardo M, Solero CL, Valsecchi MG.
Prognostic factors for survival in 676 consecutive patients with newly
diagnosed primary glioblastoma.
Neuro Oncol. 2007 Nov 9;. [Epub ahead of print]
Abstract
|
|
C. Ford, W. Seiferheld, A. K.
Choucair, J. Hansen, B. Dabbas, C. Schultz, A. Schulsinger, M. Mehta, W. Curran
Evaluation of expression of
DNA repair molecules as a prognostic factor for long-term survivors with
glioblastoma multiforme (GBM) treated on RTOG protocols with irradiation and
nitrosoureas
40th
ASCO Annual Meeting. New Orleans, LA. June 5-8, 2004. Abstract No.1509
|
|
Gamburg ES, Regine
WF, Patchell RA, Strottmann JM, Mohiuddin M, Young AB.
The
prognostic significance of midline shift at presentation on survival in patients
with glioblastoma multiforme
Int J Radiat Oncol Biol Phys 2000 Dec 1;48(5):1359-62
|
|
|
Gorlia T, van den Bent MJ, Hegi ME, Mirimanoff
RO, Weller M, Cairncross JG, Eisenhauer E, Belanger K, Brandes AA, Allgeier
A, Lacombe D, Stupp R
Nomograms for predicting survival of patients with newly diagnosed
glioblastoma: prognostic factor analysis of EORTC and NCIC trial
26981-22981/CE.3
Lancet Oncol. 2007 Dec 12; [Epub ahead of print]
Abstract |
DBLinks | BL 7:1
|
|
T. Gorlia, R. Stupp, E. A.
Eisenhauer, R. O. Mirimanoff, M. J. Van Den Bent, K. Belanger, D. Lacombe, A.
Allgeier, European Organisation for Research and Treatment of Cancer (EORTC)
Brain And Radiotherapy Groups, National Cancer Institute of Canada (NCIC)
Clinical Trials Group
Clinical prognostic factors affecting survival in
patients with newly diagnosed Glioblastoma Multiforme (GBM)
40th
ASCO Annual Meeting. New Orleans, LA. June 5-8, 2004. Abstract No.9599
|
|
Hakin-Smith
V, Jellinek DA, Levy D, Carroll T, Teo M, Timperley WR, McKay MJ, Reddel RR,
Royds JA
Alternative
lengthening of telomeres and survival in patients with glioblastoma multiforme
Lancet 2003 Mar 8;361(9360):836-8
|
|
Monika E. Hegi, Ph.D.,
Annie-Claire Diserens, M.Sc., Thierry Gorlia, M.Sc., Marie-France Hamou,
Nicolas de Tribolet, M.D., Michael Weller, M.D., Johan M. Kros, M.D.,
Johannes A. Hainfellner, M.D., Warren Mason, M.D., Luigi Mariani, M.D.,
Jacoline E.C. Bromberg, M.D., Peter Hau, M.D., René O. Mirimanoff, M.D.,
J. Gregory Cairncross, M.D., Robert C. Janzer, M.D., and Roger Stupp, M.D.
MGMT
Gene Silencing and Benefit from Temozolomide in Glioblastoma
The New England Journal of Medicine,
Volume 352:997-1003, Number 10, March 10, 2005
|
|
Monika E. Hegi,
Annie-Claire Diserens, Sophie Godard,
Pierre-Yves Dietrich, Luca Regli,
Sandrine Ostermann, Philippe Otten,
Guy Van Melle, Nicolas de Tribolet
and Roger Stupp
Clinical Trial Substantiates the Predictive Value of O-6-Methylguanine-DNA
Methyltransferase Promoter Methylation in Glioblastoma Patients
Treated with Temozolomide
Clinical Cancer Research Vol. 10, 1871-1874, 15 March 2004
|
|
|
Hulleman E, Quarto M, Vernell R, Masserdotti G,
Colli E, Kros JM, Levi D, Gaetani P, Tunici P, Finocchiaro G, Rodriguez Y
Baena R, Capra M, Helin K.
A role for the transcription factor HEY1 in glioblastoma
J Cell Mol Med. 2008 Mar 17; [Epub ahead of print]
Abstract |
Reprint |
DBLinks | BL 7:7
|
|
Keles GE, Lamborn KR, Chang SM, Prados
MD, Berger MS
Volume of residual disease as a predictor of
outcome in adult patients with recurrent supratentorial glioblastomas
multiforme who are undergoing chemotherapy
J Neurosurg. 2004 Jan;100(1):41-6
|
|
B. K. Kleinschmidt-DeMasters, MD; K. O.
Lillehei, MD; M. Varella-Garcia, PhD
Glioblastomas in the Older
Old
Arch
Pathol Lab Med. 2005 May;129(5):624-631
|
|
Koka V, Potti A, Forseen SE, Pervez H,
Fraiman GN, Koch M, Levitt R
Role
of her-2/neu overexpression and clinical determinants of early mortality
in glioblastoma multiforme
Am J Clin Oncol.
2003 Aug;26(4):332-5
|
|
H. Kobayashi, N. Ishii, J. Ikeda,
Y. Sawamura, Y. Iwasaki
Methylation
profiling of the DNA repair genes in glioblastoma multiforme and its clinical
relevance
40th
ASCO Annual Meeting. New Orleans, LA. June 5-8, 2004. Abstract No.1572
|
|
Kraus JA,
Wenghoefer M, Schmidt MC, von Deimling A, Berweiler U, Roggendorf W, Diete
S, Dietzmann K, Muller B, Heuser K, Reifenberger G, Schlegel U
Long-term
survival of glioblastoma multiforme: importance of histopathological
reevaluation
J Neurol. 2000
Jun;247(6):455-60
|
|
Lacroix M, Abi-Said D, Fourney DR, Gokaslan ZL, Shi W, DeMonte F,
Lang FF, McCutcheon IE, Hassenbusch SJ, Holland E, Hess K, Michael C, Miller
D, Sawaya R
A
multivariate analysis of 416 patients with glioblastoma multiforme:
prognosis, extent of resection, and survival
J Neurosurg. 2001
Aug;95(2):190-8
|
|
Kathleen R. Lamborn, Susan M. Chang, Michael D. Prados
Prognostic factors for survival of patients with glioblastoma: Recursive
partitioning analysis
Neuro-Oncology, Vol. 6, No. 3, July
2004, 227 -- 235. (Abstract+)
|
|
|
Leif G. Salford, Erik Nordenström, Gunnar Skagerberg, Torgil Möller,
Bengt Widegren, and Roland Perfekt
Women with Left Frontal Glioblastoma Have a Significantly Shorter
Survival—Why?
Neuro-oncol 2006; 8(4): 290-291; first published on August 31, 2006 as DOI:
10.1215/15228517-2006-017
Full
Text |
Reprint
|
|
|
Daniel A. Lim, Soonmee Cha,
Mary C. Mayo, Mei-Hsiu Chen, Evren Keles,
Scott VandenBerg and Mitchel S. Berger
Relationship of glioblastoma multiforme to neural stem cell regions
predicts invasive and multifocal tumor phenotype
Neuro Oncol 2007 Oct 1. 9(4):424-429; DOI:10.1215/15228517-2007-023. First
published on July 10, 2007
Abstract
|
Full
Text |
Reprint
|
DBLinks | BL 7:2
|
|
Maldaun MV, Suki D, Lang FF, Prabhu S, Shi W, Fuller GN,
Wildrick DM, Sawaya R
Cystic glioblastoma multiforme: survival outcomes in
22 cases
J Neurosurg. 2004 Jan;100(1):61-7
|
|
|
Mangiola A, Lama G, Giannitelli C, De Bonis P, Anile C,
Lauriola L, La Torre G, Sabatino G, Maira G, Jhanwar-Uniyal M, Sica G
Stem Cell Marker Nestin and c-Jun NH2-Terminal Kinases in Tumor and
Peritumor Areas of Glioblastoma Multiforme: Possible Prognostic Implications
Clin
Cancer Res. 2007 Dec 1;13(23):6970-6977.
Abstract |
DBLinks
|
|
|
Marchan EM, Sekula RF Jr, Jannetta PJ, Quigley
MR
Long-term survival enhanced by cordectomy in a patient with a spinal
glioblastoma multiforme and paraplegia. Case report
J Neurosurg Spine. 2007 Dec;7(6):656-9
Abstract |
DBLinks | BL 7:1
|
|
|
Ramon Martinez, Gabriele Schackert and
Manel Esteller
Hypermethylation of the proapoptotic gene TMS1/ASC: prognostic
importance in glioblastoma multiforme
J Neurooncol. 2006 Oct 18; [Epub
ahead of print]
Abstract
|
|
|
Mauer
M, Stupp R, Taphoorn MJ, Coens C, Osoba D, Marosi C, Wong R, de Witte O,
Cairncross JG, Efficace F, Mirimanoff RO, Forsyth P, van den Bent MJ, Weller
M, Bottomley A.
The prognostic value of health-related quality-of-life data in predicting
survival in glioblastoma cancer patients: results from an international
randomised phase III EORTC Brain Tumour and Radiation Oncology Groups, and
NCIC Clinical Trials Group study.
Br J Cancer.
2007 Jul 3; [Epub ahead of print]
PMID: 17609661 [PubMed - as supplied by publisher]
|
|
Parsa AT, Wachhorst S, Lamborn KR, Prados MD, McDermott MW, Berger MS,
Chang SM
Prognostic significance of intracranial dissemination of
glioblastoma multiforme in adults
J
Neurosurg. 2005 Apr;102(4):622-8
|
|
|
Ruano Y, Mollejo M, Camacho FI, de Lope AR, Fiańo
C, Ribalta T, Martínez P, Hernández-Moneo JL, Meléndez B
Identification of survival-related genes of the phosphatidylinositol
3'-kinase signaling pathway in glioblastoma multiforme
Cancer. 2008 Feb 7; [Epub
ahead of print]
Abstract |
DBLinks | BL 7:4
|
|
Saito T, Hama S, Kajiwara Y, Sugiyama K, Yamasaki F,
Arifin MT, Arita K, Kurisu K.
Prognosis of cerebellar glioblastomas: correlation between prognosis and
immunoreactivity for epidermal growth factor receptor compared with
supratentorial glioblastomas.
Anticancer Res. 2006
Mar-Apr;26(2B):1351-7.
Abstract
|
|
Scott JN, Rewcastle NB, Brasher PM, Fulton D, MacKinnon JA,
Hamilton M, Cairncross JG, Forsyth P
Which
glioblastoma multiforme patient will become a long-term survivor? A
population-based study
Ann Neurol. 1999 Aug;46(2):183-8
|
|
Scott JN,
Rewcastle NB, Brasher PM, Fulton D, Hagen NA, MacKinnon JA, Sutherland G,
Cairncross JG, Forsyth P
Long-term
glioblastoma multiforme survivors: a population-based study
Can J Neurol Sci. 1998 Aug;25(3):197-201
|
|
A.
Shet, A. E. Schorer, M. A. Kuskowski
Venous
thromboembolism is common but does not alter survival in glioblastoma multiforme
39th
ASCO Annual Meeting. Chicago, IL. May 31-June 3, 2003. Abstract No.
432
|
|
Shinojima N, Kochi M, Hamada J, Nakamura H, Yano S, Makino K, Tsuiki H, Tada
K, Kuratsu J, Ishimaru Y, Ushio Y
The influence of sex and the presence of giant cells on
postoperative long-term survival in adult patients with supratentorial
glioblastoma multiforme
J Neurosurg. 2004 Aug;101(2):219-26
|
|
Simon, Matthias M.D.; Ludwig, Michael Ph.D.; Fimmers, Rolf Ph.D.; Mahlberg,
Ralph; Muller-Erkwoh, Angelika M.D.; Koster, Gertraud Ph.D.; Schramm, Johannes
M.D.
Variant Of The Chek2 Gene As A Prognostic Marker In Glioblastoma Multiforme.
Clinicopathological Study
Neurosurgery. 2006 Sep 28; [Epub ahead of
print]
Abstract
|
|
Simpson JR, Horton J, Scott C, Curran WJ, Rubin P,
Fischbach J, Isaacson S, Rotman M, Asbell SO, Nelson JS, et al
Influence of location and
extent of surgical resection on survival of patients with glioblastoma
multiforme: results of three consecutive Radiation Therapy Oncology Group
(RTOG) clinical trials
Int J Radiat Oncol Biol Phys. 1993 May 20;26(2):239-44
|
|
|
Swanson KR, Rostomily RC, Alvord EC Jr
A mathematical modelling tool for predicting survival of individual
patients following resection of glioblastoma: a proof of principle
Br J Cancer. 2007 Dec 4;. [Epub ahead of print]
Abstract |
Full Text |
Reprint
|
DBLinks | BL 7:1
|
|
|
Wang LF, Fokas E, Juricko J, You A, Rose F,
Pagenstecher A, Engenhart-Cabillic R, An HX.
Increased expression of EphA7 correlates with adverse outcome in primary
and recurrent glioblastoma multiforme patients
BMC Cancer. 2008 Mar 25;8(1):79
Abstract |
Full Text |
Reprint |
DBLinks | BL 7:7
|
|
|
Gliomas
|
|
|
|
|
Basso U, Monfardini S, Brandes AA
Recommendations for the
management of malignant gliomas in the elderly
Expert Rev Anticancer Ther. 2003 Oct;3(5):643-54
|
|
Batistatou A, Kyzas PA, Goussia A, Arkoumani E,
Voulgaris S, Polyzoidis K, Agnantis NJ, Stefanou D.
Estrogen receptor beta (ERbeta) protein expression correlates with BAG-1 and
prognosis in brain glial tumours.
J Neurooncol. 2006 Mar;77(1):17-23. Epub 2005 Nov 15.
Abstract
|
|
P. D. Brown, K. V. Ballman, T. A.
Rummans, M. J. Maurer, J. A. Sloan, B. F. Boeve, R. M. Arusell, M. M. Clark, J.
C. Buckner
Prospective NCCTG quality of life (QOL)
study in adult newly diagnosed high-grade gliomas (HGG)
40th
ASCO Annual Meeting. New Orleans, LA. June 5-8, 2004. Abstract No.1524
|
| |
Brown PD, Buckner JC, O'Fallon JR, Iturria NL, O'Neill BP, Brown
CA, Scheithauer BW, Dinapoli RP, Arusell RM, Curran WJ, Abrams R, Shaw EG
Importance
of baseline mini-mental state examination as a prognostic factor for patients
with low-grade glioma
Int J Radiat Oncol Biol Phys. 2004
May 1;59(1):117-25
|
|
Bucci MK, Maity A, Janss AJ, Belasco JB, Fisher MJ, Tochner ZA, Rorke L,
Sutton LN, Phillips PC, Shu HK
Near complete surgical resection predicts a favorable outcome
in pediatric patients with nonbrainstem, malignant gliomas: results from a
single center in the magnetic resonance imaging era
Cancer. 2004 Aug 15;101(4):817-24
|
| |
Buckner JC
Factors influencing survival in high-grade gliomas
Semin Oncol. 2003 Dec;30(6 Suppl 19):10-4
|
|
J.
C. Buckner, B. W. Scheithauer, J. R. O'Fallon, P. Schaefer, C. Giannini, K.
Ballman, R. Jenkins
p53, EGFR, and PTEN as markers of diagnosis and
prognosis in patients with anaplastic glioma enrolled in NCCTG clinical trials
39th ASCO Annual Meeting. Chicago, IL. May 31-June 3, 2003. Abstract No.
393
|
| |
Cao Y, Tsien CI, Nagesh V, Junck L, Ten Haken
R, Ross BD, Chenevert TL, Lawrence TS
Clinical investigation survival
prediction in high-grade gliomas by MRI perfusion before and during early stage
of RT
Int
J Radiat Oncol Biol Phys. 2005 Nov 17;
[Epub ahead of print]
|
|
K. Carson, S. A. Grossman,
J. D. Fisher and E. Shaw
Prognostic factors for survival in
adult patients with recurrent glioma enrolled on New Approaches to Brain Tumor
Therapy (NABTT) CNS Consortium phase I and II clinical trials
2005
ASCO Annual Meeting. Orlando, FL. May 13-17. Abstract No. 1509
Journal of Clinical Oncology, Vol 23, No 16S (June 1 Supplement), 2005:
1509
|
|
WJ Curran Jr, CB Scott, J Horton, JS Nelson, AS Weinstein, AJ
Fischbach, CH Chang, M Rotman, SO Asbell and RE Krisch
Recursive partitioning analysis of prognostic factors in three Radiation
Therapy Oncology Group malignant glioma trials
Journal Of The National Cancer Institute, Volume 85, Issue 9 :
May 5, 1993, 704-710
|
|
Curran WJ
Jr, Scott CB, Weinstein AS, Martin LA, Nelson JS, Phillips TL, Murray K,
Fischbach AJ, Yakar D, Schwade JG, et al.
Survival
comparison of radiosurgery-eligible and -ineligible malignant glioma patients
treated with hyperfractionated radiation therapy and carmustine: a report of
Radiation Therapy Oncology Group 83-02
J Clin Oncol. 1993 May;11(5):857-62
|
| |
De
Witte O, Goldberg I, Wikler D, Rorive S, Damhaut P, Monclus M, Salmon I,
Brotchi J, Goldman S
Positron emission tomography with
injection of methionine as a prognostic factor in glioma
J
Neurosurg. 2001 Nov;95(5):746-50)
|
|
A.
Flowers
Management of malignant
gliomas at Hartford Hospital: Patterns of care and outcomes
39th ASCO Annual Meeting.
Chicago, IL. May 31-June 3, 2003. Abstract No.
464)
|
| |
E.
Galanis, M. J. Maurer, K. V. Ballman, J. O'Fallon, R. Sykora, R. Castillo,
J. C. Buckner, B. J. Erickson
Validation of neuroradiologic response
assessment in gliomas: RECIST (1D) vs 2D measurements vs computer-assisted tumor
area vs volume
39th ASCO Annual Meeting.
Chicago, IL. May 31-June 3, 2003. Abstract No.
423
|
|
|
Gennadi V. Glinsky, Olga
Berezovska and Anna B. Glinskii
Microarray analysis identifies a death-from-cancer signature predicting
therapy failure in patients with multiple types of cancer
J. Clin. Invest. 115:1503-1521 (1 June 2005)
Abstract
|
Full
Text |
Reprint
|
|
|
Halperin EC
Malignant gliomas in older
adults with poor prognostic signs. Getting nowhere, and taking a long time
to do it
Oncology (Huntingt). 1995 Mar;9(3):229-34; discussion 237-8, 243
|
|
Huncharek
M, Muscat J
Treatment
of recurrent high grade astrocytoma; results of a systematic review of 1,415
patients
Anticancer Res. 1998 Mar-Apr; 18(2B): 1303-11
|
|
Yasushi
Ino,
M.D., Magdalena
C. Zlatescu,
M.D., Hikaru
Sasaki,
M.D., Ph.D.,
David
R. Macdonald,
M.D., Anat
O. Stemmer-Rachamimov,
M.D., Sarah
Jhung,
B.S., David
A. Ramsay,
M.D., Andreas
Von Deimling,
M.D., David
N. Louis,
M.D., And
J. Gregory
Cairncross,
M.D.
Long
survival and therapeutic responses in patients with histologically
disparate high-grade gliomas demonstrating chromosome 1p loss
J Neurosurg.,
92:983–990, June 2000
|
|
|
Iwamoto FM, Nicolardi L, Demopoulos A,
Barbashina V, Salazar P, Rosenblum M, Hormigo A.
Clinical relevance of 1p and 19q deletion for patients with WHO grade 2
and 3 gliomas
J Neurooncol.
2008 Mar 15; [Epub ahead of print]
Abstract |
DBLinks | BL 7:7
|
|
Jeremic B, Milicic B, Grujicic D, Dagovic A, Aleksandrovic
J, Nikolic N
Clinical prognostic factors in patients with
malignant glioma treated with combined modality approach
Am J Clin Oncol. 2004 Apr;27(2):195-204
|
|
Klein M,
Postma TJ, Taphoorn MJ, Aaronson NK, Vandertop WP, Muller M, Van Der Ploeg HM,
Heimans JJ
The
prognostic value of cognitive functioning in the survival of patients with
high-grade glioma
Neurology. 2003 Dec 23;61(12):1796-8
|
| |
Kuznetsov YE, Caramanos Z, Antel SB, Preul MC, Leblanc R,
Villemure JG, Pokrupa R, Olivier A, Sadikot A, Arnold DL
Proton magnetic resonance spectroscopic imaging can
predict length of survival in patients with supratentorial gliomas
Neurosurgery. 2003 Sep;53(3):565-76
|
|
B. E. Lally, J. M. Colasanto,
J. P. S. Knisely
The prognostic effect of hemoglobin levels on
survival for patients with high-grade gliomas
40th
ASCO Annual Meeting. New Orleans, LA. June 5-8, 2004. Abstract No.1565)
|
|
Laws ER, Parney IF, Huang W, Anderson F, Morris AM,
Asher A, Lillehei KO, Bernstein M, Brem H, Sloan A, Berger MS, Chang S;
Glioma Outcomes Investigators
Survival following surgery
and prognostic factors for recently diagnosed malignant glioma: data from
the Glioma Outcomes Project
J Neurosurg. 2003 Sep;99(3):467-73
|
|
Ljubimova JY, Fugita M, Khazenzon NM, Das A, Pikul BB, Newman D, Sekiguchi K,
Sorokin LM, Sasaki T, Black KL
Association between laminin-8 and glial tumor grade,
recurrence, and patient survival
Cancer. 2004 Aug 1;101(3):604-12
|
|
Murovic
J, Turowski K, Wilson CB, Hoshino T, Levin V
Computerized
tomography in the prognosis of malignant cerebral gliomas
J
Neurosurg 1986 Dec;65(6):799-806
|
|
Satoshi
Nakasu, Tadateru Fukami, Kazumi Baba, Masayuki Matsuda
Immunohistochemical
study for O6-methylguanine-DNA methyltransferase in the
non-neoplastic and neoplastic components of gliomas
Journal
of Neuro-Oncology, 70(3):
333-340, December 2004. (Abstract+)
|
| |
Nieder C, Grosu AL, Molls M
A
comparison of treatment results for recurrent malignant gliomas
Cancer Treat Rev. 2000 Dec; 26(6): 397-409
|
|
M.V. Padma, S. Said,
M. Jacobs, D.R. Hwang, K. Dunigan, M. Satter, B. Christian, J. Ruppert, T.
Bernstein, G. Kraus, J.C. Mantil
Prediction of Pathology and Survival by FDG PET in Gliomas
Journal of Neuro-Oncology, 64 (3): 227-237, September 2003
|
|
Ian F. Pollack, Ronald
L. Hamilton, Robert W. Sobol, Judith Burnham,
Allan J. Yates, Emiko J. Holmes, Tianni
Zhou, Jonathan L. Finlay
O6-Methylguanine-DNA
Methyltransferase Expression Strongly Correlates With Outcome in Childhood
Malignant Gliomas: Results From the CCG-945 Cohort
Journal of Clinical Oncology, Vol 24, No 21 (July 20), 2006: pp. 3431-3437;
DOI: 10.1200/JCO.2006.05.7265
|
|
R.
D. Rao, R. Jenkins, B. W. Scheithauer, J. R. O'Fallon, A. Furth, A.
Furth, N. Iturria, P. Schaefer, J. C. Buckner
Correlations
between cytological subtypes and cytogenetic aberrations in high grade
gliomas
39th
ASCO Annual Meeting. Chicago, IL. May 31-June 3, 2003. Abstract No.
422
|
|
S.
N. Raval, B. Gu, J. J. Raizer, M. K. Rosenblum, D. Banerjee, J. R.
Bertino, L. M. DeAngelis
Methylation of MGMT promotor, the DNA repair gene
as an independent prognostic factor for malignant glioma
39th ASCO Annual Meeting.
Chicago, IL. May 31-June 3, 2003. Abstract No.
452
|
|
Andrea Salmaggi, Marica Eoli, Simona Frigerio, Antonio
Silvani, Maurizio Gelati, Elena Corsini, Giovanni Broggi, Amerigo Boiardi
Intracavitary
VEGF, bFGF, IL-8, IL-12 levels in primary and recurrent malignant glioma
Journal of Neuro-Oncology,
62 (3): 297-303, May
2003
|
|
Shono T,
Tofilon PJ, Bruner JM, Owolabi O, Lang FF
Cyclooxygenase-2
expression in human gliomas: prognostic significance and molecular correlations
Cancer Res 2001 Jun 1;61(11):4375-81
|
|
Stewart LA
Chemotherapy in adult
high-grade glioma: a systematic review and meta-analysis of individual
patient data from 12 randomised trials
Lancet. 2002 Mar 23;359(9311):1011-8
|
| |
Stupp R, Janzer RC, Hegi ME, Villemure JG, Mirimanoff RO
Prognostic factors for low-grade gliomas
Semin Oncol. 2003 Dec;30(6 Suppl 19):23-8
|
|
Takahashi Y,
Imahori Y, Mineura K
Prognostic
and therapeutic indicator of fluoroboronophenylalanine positron emission
tomography in patients with gliomas
Clin Cancer Res. 2003 Dec 1;9(16):5888-95
|
|
Avelina
Tortosa, Nuria Vinolas, Salvador Villa, Eugenia Verger, Juan M Gil, Marta Brell,
Lluis Caral, Teresa Pujol, Juan Jose Acebes, Teresa Ribalta, Isidre Ferrer,
Francesc Graus
Prognostic
implication of clinical, radiological, and pathological features in patients
with anaplastic glioma
38th
ASCO Annual Meeting. Orlando, FL. May 18-21, 2002.
304
|
|
Vuorinen V, Hinkka S, Farkkila M, Jaaskelainen J
Debulking or biopsy of
malignant glioma in elderly people - a randomised study
Acta Neurochir (Wien). 2003 Jan;145(1):5-10
|
|
J.
H. Wisoff, A. Sanford, E. Holmes, R. Sposto, L. Kun, L. Heier, P.
Burger, A. Yates
Impact of
surgical resection on low grade gliomas of childhood: A report from the
CCG9891/POG9130 low grade astrocytoma study
39th ASCO Annual Meeting.
Chicago, IL. May 31-June 3, 2003. Abstract No.
401
|
|
Wong
ET, Hess KR, Gleason MJ, Jaeckle KA, Kyritsis AP, Prados MD, Levin VA, Yung
WK
Outcomes
and prognostic factors in recurrent glioma patients enrolled onto phase II
clinical trials
J Clin Oncol. 1999 Aug;17(8):2572
|
|
|
Zeppernick F, Ahmadi R, Campos B, Dictus C,
Helmke BM, Becker N, Lichter P, Unterberg A, Radlwimmer B, Herold-Mende CC
Stem Cell Marker CD133 Affects Clinical Outcome in Glioma Patients
Clin Cancer Res. 2008 Jan 1;14(1):123-9
Abstract |
DBLinks | BL 7:2
|
|
Yi-Hong Zhou, Kenneth R. Hess, W. K. Alfred
Yung
Prognostic model for glioma patients
Proceedings of the AACR, Volume 45, March 2004, Abstract
Number: 1078
|
|
Yi-Hong Zhou, Fang Tan, Kenneth R. Hess
and W. K. Alfred Yung
The Expression of PAX6, PTEN, Vascular Endothelial Growth Factor, and
Epidermal Growth Factor Receptor in Gliomas. Relationship to Tumor Grade and Survival
Clinical Cancer Research Vol. 9, 3369-3375, August 2003
|
|
Brainstem
Gliomas |
|
|
|
Kesari
S, Kim RS, Markos V, Drappatz J, Wen PY, Pruitt AA
Prognostic factors in adult brainstem gliomas: a multicenter, retrospective
analysis of 101 cases
J Neurooncol.
2008 Mar 26; [Epub ahead of print]
Abstract |
DBLinks | BL 7:8
|
|
Primary
Spinal Gliomas |
|
|
Jen-Ho Tseng, Ming-Yuan Tseng
Survival Analysis of 81 Children with Primary
Spinal Gliomas: A Population-Based Study
Pediatr Neurosurg. 2006 Oct;42(6):347-53.
Abstract
|
|
|
Gliomas
(High Grade)
|
|
|
|
|
Fadime Akman, Rachel A. Cooper, Mehmet Şen,
Yildiray Tanriver, Süleyman Kentli
Validation of the Medical Research Council and A Newly Developed Prognostic
Index in Patients with Malignant Glioma:
How useful are Prognostic Indices in
Routine Clinical Practice?
Journal of Neuro-Oncology, 59 (1): 39-47, August 2002
Abstract |
| |
